MDR1 and MRP expression in chronic B-cell lymphoproliferative disorders. (Q54126502)

25 May 2018

title

MDR1 and MRP expression in chronic B-cell lymphoproliferative disorders. (English)

1 reference

25 May 2018

author

David Le Couteur

4

1 reference

25 May 2018

author name string

M Webb

1

1 reference

25 May 2018

M Brun

2

1 reference

25 May 2018

M McNiven

3

1 reference

25 May 2018

P Craft

5

1 reference

25 May 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

25 May 2018

British Journal of Haematology

published in

1 reference

25 May 2018

volume

102

1 reference

25 May 2018

issue

3

1 reference

25 May 2018

page(s)

710-717

1 reference

25 May 2018

High mdr1- and mrp-, but low topoisomerase II alpha-gene expression in B-cell chronic lymphocytic leukaemias

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00822.X

High expression of the multidrug resistance-associated protein (MRP) in chronic and prolymphocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00822.X

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00822.X

Isolation and expression of a complementary DNA that confers multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00822.X

Peripheral blood cell preparation influences the level of expression of leukocyte cell surface markers as assessed with quantitative multicolor flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00822.X

The detection of rhodamine 123 efflux at low levels of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00822.X

The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00822.X

The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00822.X

Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00822.X

Analysis of multidrug resistance (MDR-1) gene expression in chronic lymphocytic leukaemia (CLL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00822.X

Common expression of the multidrug resistance marker P-glycoprotein in B-cell chronic lymphocytic leukaemia and correlation with in vitro drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00822.X

MDR1 Gene Expression in Chronic Lymphocytic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00822.X

Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00822.X

10.1046/J.1365-2141.1998.00822.X

21 January 2018

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018